Personalized blood glucose models for exercise, meal and insulin interventions in type 1 diabetic children

Naviyn P Balakrishnan1, Gade P Rangaiah, Lakshminarayanan Samavedham

  • 1National University of Singapore, Department of Chemical & Biomolecular Engineering, Singapore. naviyn@nus.edu.sg

Insights

Personalized blood glucose (BG) prediction models were developed for 12 children with type 1 diabetes (T1D). These models incorporate lifestyle factors to optimize treatment and prevent complications.

Area of Science:

  • Biomedical Engineering
  • Endocrinology
  • Computational Biology

Background:

  • Modern healthcare trends emphasize personalized, predictive, preventive, and participatory (P4) medicine to enhance patient quality of life (QoL).
  • Accurate blood glucose (BG) prediction models that integrate lifestyle interventions are crucial for preventing hypoglycemia and diabetes complications in type 1 diabetes (T1D).

Purpose of the Study:

  • To develop personalized BG prediction models for T1D children by incorporating lifestyle interventions.
  • To utilize time series modeling to create patient-specific BG forecasting tools.

Main Methods:

  • Employed multi-input single-output time series models to develop personalized BG models for 12 T1D children.
  • Utilized clinical data including rate of perceived exertion (RPE), carbohydrate absorption, and insulin kinetics as model inputs.
  • Applied linear models (Box-Jenkins, state space, process transfer function) and nonlinear Hammerstein-Wiener models.

Main Results:

  • Successfully developed personalized BG models for all 12 T1D children, capturing inter-patient variability.
  • Linear models were suitable for 9 patients, while nonlinear Hammerstein-Wiener models were optimal for the remaining 3.
  • Demonstrated the feasibility of using diverse modeling approaches to create individualized BG prediction systems.

Conclusions:

  • Personalized BG prediction models integrating lifestyle factors are achievable for T1D children.
  • The developed models can aid in creating tailored exercise, diet, and insulin prescriptions.
  • This approach holds potential for improving diabetes management and preventing adverse events.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...